title: Atrial Fibrillation is Associated With Poor Outcomes in Thrombolyzed Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
abstract: The influence of atrial fibrillation (AF) on the clinical outcomes of patients with ischemic stroke (IS) has not been completely determined. We aimed to perform a systematic review and meta-analysis to assess the relationship between AF and adverse events in patients with acute IS treated with thrombolysis.PubMed, EMBASE, and the Cochrane Library were searched for relevant studies regarding the association between AF and the outcomes of patients with IS treated with thrombolysis. Random and fixed effect models were used for pooling data.Twelve cohort studies involving 14,801 patients with acute IS were included. Meta-analysis revealed that patients with AF were more likely to die within 90 days after thrombolysis (odds ratio [OR], 2.13; 95% confidence interval [CI]: 1.68-2.70, P < 0.001), whereas this association was not observed in hospitalized patients (OR, 1.50; 95% CI, 0.86-2.60; P = 0.150). AF was associated with a reduced incidence of favorable outcomes (modified Rankin Scale ≤ 2) (OR, 1.95; 95% CI: 1.33-2.85, P = 0.001) and an increased risk of symptomatic intracerebral hemorrhage (OR, 1.28; 95% CI: 1.08-1.52, P = 0.006). No evident publication bias was found by Begg's test or Egger's test.Comorbidity of AF may increase the risk of adverse outcomes for patients with IS undergoing thrombolysis. Further well-designed trials are warranted to confirm this association.
authors.affiliation: From the Department of Nephrology (RY, SH); Department of Cardiology (DL, JY, ZZ, XS, RZ), West China Hospital, Sichuan University, Chengdu; Department of Cardiology (SL), First Affiliated Hospital of Xinjiang Medical University; and School of Public Health (YM), Xinjiang Medical University, Urumqi, China.
authors.forename: Rongzheng
authors.initials: R
authors.lastname: Yue
authors.forename: Dongze
authors.initials: D
authors.lastname: Li
authors.forename: Jing
authors.initials: J
authors.lastname: Yu
authors.forename: Shuangshuang
authors.initials: S
authors.lastname: Li
authors.forename: Yan
authors.initials: Y
authors.lastname: Ma
authors.forename: Songmin
authors.initials: S
authors.lastname: Huang
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zeng
authors.forename: Rui
authors.initials: R
authors.lastname: Zeng
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Sun
mesh_terms: D000208:Acute Disease; D001281:Atrial Fibrillation / Q000150:complications*; D002545:Brain Ischemia / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D015994:Incidence; D011379:Prognosis; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D005343:Fibrinolytic Agents